Chimerism (Post-transplant)

Chimerism (Post-transplant) measures the levels of donor and recipient cells after a transplant. It helps determine the transplant's success, detect rejection, assess relapse risk, and guide treatment decisions post-transplant.

Chimerism (Post-transplant) is conducted for various reasons:

• To assess the effectiveness of organ or bone marrow transplant
• To detect and manage rejection or relapse after the transplant
• To tailor treatment strategies based on chimerism results

Chimerism (Post-transplant) is advised for:

• Recipients of organ or bone marrow transplants
• Individuals showing signs of rejection or relapse post-transplant
• Patients requiring close monitoring after transplantation

Abnormal results may suggest graft rejection or complications post-transplant. Discuss the results with your doctor for further evaluation and management.

You can expect:

• Blood sample collection over several time points post-transplant
• Non-invasive procedure where blood is drawn from a vein
• Minimal discomfort during sample collection

Before undergoing Chimerism testing:

• Follow your doctor's instructions on fasting or specific dietary restrictions
• Inform your doctor about any medications you are taking
• Ensure you are well-rested for accurate test results

Other tests may include:

• Micro-chimerism Testing: Identifies minor populations of foreign cells in the body
• Graft-versus-host Disease Testing: Checks for adverse immune reactions post-transplant
• Donor-Specific Antibody Testing: Assesses immune response post-transplant
• Graft Biopsy: Examines tissue samples to evaluate transplant health

• Donor and Recipient Cell Ratio Analysis
• Post-transplant Cell Monitoring
• Chimerism Analysis

Organ transplantation involves surgically replacing a damaged organ with a healthy one from a donor to improve the recipient's health and quality of life. This process aims to restore normal bodily functions and treat severe organ-related diseases.